Clinical Trials Browser

Phase 3 × INDUSTRY × Adalimumab × Clear all

NCT05073315 2024-02-09

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

Phase 3 Completed

425 enrolled 22 charts

Plaque Psoriasis

NCT02762955 2021-09-08

CALYPSO

Phase 3 Completed

Psoriasis

NCT02163759 2021-07-23

HIBISCUS I

Phase 3 Completed

358 enrolled 42 charts

Colitis, Ulcerative

NCT02171429 2021-07-23

HIBISCUS II

Phase 3 Completed

358 enrolled 38 charts

Colitis, Ulcerative

NCT02499783 2019-01-04

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

Phase 3 Completed

205 enrolled 39 charts

Crohn Disease

NCT02893254 2018-06-04

Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis

Phase 3 Completed

Spondylitis, Ankylosing

NCT02196701 2018-03-19

CLEAR

Phase 3 Completed

46 enrolled 27 charts

Psoriasis

NCT01635764 2018-01-24

PIONEER (OLE)

Phase 3 Completed

508 enrolled 9 charts

Abscess, Acne Vulgaris, Hidradenitis Suppurativa

NCT00085644 2011-04-21

ATLAS

Phase 3 Completed

315 enrolled 45 charts

Spondylitis, Ankylosing